Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate OraSure Technologies, Inc. before investing.

In this article, we go over a few key elements for understanding OraSure Technologies, Inc.’s stock price such as:

• OraSure Technologies, Inc.’s current stock price and volume
• Why OraSure Technologies, Inc.’s stock price changed recently
• Upgrades and downgrades for OSUR from analysts
• OSUR’s stock price momentum as measured by its relative strength

About OraSure Technologies, Inc. (OSUR)

Before we jump into OraSure Technologies, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.

Want to learn more about OraSure Technologies, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about OraSure Technologies, Inc..

OraSure Technologies, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, OraSure Technologies, Inc.’s stock price was $4.050.

OraSure Technologies, Inc. is up 2.02% from its previous closing price of $3.970.

During the last market session, OraSure Technologies, Inc.’s stock traded between $3.865 and $4.080. Currently, there are approximately 69.68 million shares outstanding for OraSure Technologies, Inc..

OraSure Technologies, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

OraSure Technologies, Inc. Stock Price History

OraSure Technologies, Inc.’s (OSUR) price is currently down 9.19% so far this month.

During the month of July, OraSure Technologies, Inc.’s stock price has reached a high of $4.510 and a low of $3.705.

Over the last year, OraSure Technologies, Inc. has hit prices as high as $4.580 and as low as $2.080. Year to date, OraSure Technologies, Inc.’s stock is up 67.36%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused OraSure Technologies, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded OraSure Technologies, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate OraSure Technologies, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on OraSure Technologies, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

OraSure Technologies, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about OraSure Technologies, Inc. (OSUR) by visiting AAII Stock Evaluator.

Relative Price Strength of OraSure Technologies, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, OraSure Technologies, Inc. has a weighted four-quarter relative price strength of 7.52%, which translates to a Momentum Score of 76 and is considered to be Strong.

Want to learn more about how OraSure Technologies, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

OraSure Technologies, Inc. Stock Price: Bottom Line

As of July 31, 2026, OraSure Technologies, Inc.’s stock price is $4.050, which is up 2.02% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like OraSure Technologies, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.